Siu LL - Search Results

1

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.

Davis AJ, Gelmon KA, Siu LL, Moore MJ, Britten CD, Mistry N, Klamut H, D'Aloisio S, MacLean M, Wainman N, Ayers D, Firby P, Besterman JM, Reid GK, Eisenhauer EA. Davis AJ, et al. Among authors: siu ll. Invest New Drugs. 2003 Feb;21(1):85-97. doi: 10.1023/a:1022976528441. Invest New Drugs. 2003. PMID: 12795533 Clinical Trial.

2

Other chemotherapy regimens including mitoxantrone and suramin.

Siu LL, Moore MJ. Siu LL, et al. Semin Urol Oncol. 1997 Feb;15(1):20-7. Semin Urol Oncol. 1997. PMID: 9050136 Review.

3

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

Siu LL, Chapman W, Moore MJ. Siu LL, et al. Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004. Am J Clin Oncol. 1997. PMID: 9391539

4

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ. Siu LL, et al. J Clin Oncol. 1998 Mar;16(3):1122-30. doi: 10.1200/JCO.1998.16.3.1122. J Clin Oncol. 1998. PMID: 9508199 Clinical Trial.

5

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

Siu LL, Banerjee D, Khurana RJ, Pan X, Pflueger R, Tannock IF, Moore MJ. Siu LL, et al. Clin Cancer Res. 1998 Mar;4(3):559-65. Clin Cancer Res. 1998. PMID: 9533522

6

Use of mesna to prevent ifosfamide-induced urotoxicity.

Siu LL, Moore MJ. Siu LL, et al. Support Care Cancer. 1998 Mar;6(2):144-54. doi: 10.1007/s005200050149. Support Care Cancer. 1998. PMID: 9540174 Review.

7

A phase II study of temozolomide in advanced untreated pancreatic cancer.

Moore MJ, Feld R, Hedley D, Oza A, Siu LL. Moore MJ, et al. Among authors: siu ll. Invest New Drugs. 1998;16(1):77-9. doi: 10.1023/a:1006043332368. Invest New Drugs. 1998. PMID: 9740547 Clinical Trial.

8

Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units.

Siu LL, Von Hoff DD, Rephaeli A, Izbicka E, Cerna C, Gomez L, Rowinsky EK, Eckhardt SG. Siu LL, et al. Invest New Drugs. 1998;16(2):113-9. doi: 10.1023/a:1006049227744. Invest New Drugs. 1998. PMID: 9848574

9

Telomerase: therapeutic potential in cancer.

Davis AJ, Siu LL. Davis AJ, et al. Among authors: siu ll. Cancer Invest. 2000;18(3):269-77. doi: 10.3109/07357900009031830. Cancer Invest. 2000. PMID: 10754994 Review. No abstract available.

10

Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.

Britten CD, Baker SD, Denis LJ, Johnson T, Drengler R, Siu LL, Duchin K, Kuhn J, Rowinsky EK. Britten CD, et al. Among authors: siu ll. Clin Cancer Res. 2000 Sep;6(9):3459-68. Clin Cancer Res. 2000. PMID: 10999729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters